series-b
Stage
2019
Founded
2
Investors
About
Outpace develops AI-powered protein design technologies to create engineered cell therapies that improve the efficacy, safety, and persistence of treatments targeting solid tumors.
Explore Outpace's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.